<table border="1" id="id_8be5c156-37ab-4ba2-837a-7ea1ec4b9a2d" width="498" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2: Active-Controlled Trial of Glipizide and Metformin Hydrochloride Tablets in Patients With Inadequate Glycemic Control on Diet and Exercise Alone: Summary of Trial Data at 24 Weeks</caption>
<col span="1" width="22.9%"></col>
<col span="1" width="22.9%"></col>
<col span="1" width="22.9%"></col>
<col span="1" width="16.9%"></col>
<col span="1" width="14.5%"></col>
<tbody>
<tr>
<td></td>
<td>
<content stylecode="bold">Glipizide 5 mg Tablets</content>
</td>
<td>
<content stylecode="bold">Metformin 500 mg Tablets</content>
</td>
<td>
<content stylecode="bold">Glipizide and Metformin Hydrochloride Tablets, 2.5 mg/250 mg</content>
</td>
<td>
<content stylecode="bold">Glipizide and Metformin Hydrochloride Tablets, 2.5 mg/500 mg</content>
</td>
</tr>
<tr>
<td>
<content stylecode="bold">Mean Final Dose</content>
</td>
<td>16.7 mg</td>
<td>1749 mg</td>
<td>7.9 mg/791 mg</td>
<td>7.4 mg/1477 mg</td>
</tr>
<tr>
<td>
<content stylecode="bold">Hemoglobin A</content>
<sub>1c </sub>
<content stylecode="bold">(%)</content>
</td>
<td>N = 168</td>
<td>N = 171</td>
<td>N = 166</td>
<td>N = 163</td>
</tr>
<tr>
<td>Baseline Mean</td>
<td>9.17</td>
<td>9.15</td>
<td>9.06</td>
<td>9.10</td>
</tr>
<tr>
<td>Final Mean</td>
<td>7.36</td>
<td>7.67</td>
<td>6.93</td>
<td>6.95</td>
</tr>
<tr>
<td>Adjusted Mean Change from Baseline</td>
<td>-1.77</td>
<td>-1.46</td>
<td>-2.15</td>
<td>-2.14</td>
</tr>
<tr>
<td>Difference from Glipizide</td>
<td></td>
<td></td>
<td>-0.38<linkhtml href="#footnote-1">*</linkhtml>
</td>
<td>-0.37<footnoteref idref="id-922f8641-2d1b-41af-ae86-813f8c587993"></footnoteref>
</td>
</tr>
<tr>
<td>Difference from Metformin</td>
<td></td>
<td></td>
<td>-0.70<footnoteref idref="id-922f8641-2d1b-41af-ae86-813f8c587993"></footnoteref>
</td>
<td>-0.69<footnoteref idref="id-922f8641-2d1b-41af-ae86-813f8c587993"></footnoteref>
</td>
</tr>
<tr>
<td>% Patients with Final HbA<sub>1c</sub> &lt; 7%</td>
<td>43.5%</td>
<td>35.1%</td>
<td>59.6%</td>
<td>57.1%</td>
</tr>
<tr>
<td>
<content stylecode="bold">Fasting Plasma Glucose (mg/dL)</content>
</td>
<td>N = 169</td>
<td>N = 176</td>
<td>N = 170</td>
<td>N = 169</td>
</tr>
<tr>
<td>Baseline Mean</td>
<td>210.7</td>
<td>207.4</td>
<td>206.8</td>
<td>203.1</td>
</tr>
<tr>
<td>Final Mean</td>
<td>162.1</td>
<td>163.8</td>
<td>152.1</td>
<td>148.7</td>
</tr>
<tr>
<td>Adjusted Mean Change from Baseline</td>
<td>-46.2</td>
<td>-42.9</td>
<td>-54.2</td>
<td>-56.5</td>
</tr>
<tr>
<td>Difference from Glipizide</td>
<td></td>
<td></td>
<td>-8.0</td>
<td>-10.4</td>
</tr>
<tr>
<td>Difference from Metformin</td>
<td></td>
<td></td>
<td>-11.3</td>
<td>-13.6</td>
</tr>
<tr>
<td>
<br/>
</td>
</tr>
</tbody>
</table>